Skip to main content
. 2017 Jul 7;12(7):e0180710. doi: 10.1371/journal.pone.0180710

Fig 1. PD149163 decreases operant responding for METH in mice.

Fig 1

(A) Systemic injection (s.c.) of both doses of PD149163 resulted in a significant decrease in nose pokes (FR3) made during 2-hour operant METH self-administration sessions. * P < 0.05 versus saline, Dunnett’s multiple comparison test. (B) Both doses of PD149163 also produced a significant decrease in number of METH infusions. * P < 0.05 versus saline, Dunnett’s multiple comparison test.